Search research articles
Contact Us
Filters
Showing results (91-100 of 145) with videos related to
Page
of 15
Sort By:
Acta Endocrinologica
|
September 1, 1993
Restoration of gallbladder contractility after withdrawal of long-term octreotide therapy in acromegalic patients
Y F Shi, X F Zhu, A G Harris, et al.
Acta Endocrinologica
|
November 1, 1993
Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients
T Laursen, J O Jørgensen, H Orskov, et al.
Medicine
|
September 1, 1994
Acromegaly. Clinical and biochemical features in 500 patients
S Ezzat, M J Forster, P Berchtold, et al.
Neurosurgery
|
October 8, 1997
A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas. French Multicenter Octreotide Study Group
A Warnet, A G Harris, E Renard, et al.
Hormone Research
|
January 1, 1989
Experience of a six-month treatment with sandostatin at increasing doses in acromegaly
G Sassolas, P Fossati, P Chanson, et al.
Digestive Diseases and Sciences
|
April 1, 1991
Pilot study of sandostatin (octreotide) therapy of refractory HIV-associated diarrhea
M Fanning, M Monte, L R Sutherland, et al.
Kidney International
|
April 1, 1992
Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion
A Flyvbjerg, S M Marshall, J Frystyk, et al.
Acta Endocrinologica
|
April 1, 1991
Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995)
A Warnet, E Lajeunie, F Gelbert, et al.
The American Journal of Physiology
|
April 8, 1998
Mechanisms of cell injury in rat mesentery and cremaster muscle
A G Harris, J J Costa, F A Delano, et al.
Microcirculation (New York, N.Y. : 1994)
|
September 29, 1999
Mast cell degranulation and parenchymal cell injury in the rat mesentery
J J Costa, A G Harris, F A Delano, et al.
Page
of 15
Search research articles
Search
Showing results (91-100 of 145) with videos related to
Sort By:
Page
of 15
Acta Endocrinologica
|
September 1, 1993
Restoration of gallbladder contractility after withdrawal of long-term octreotide therapy in acromegalic patients
Y F Shi, X F Zhu, A G Harris, et al.
Acta Endocrinologica
|
November 1, 1993
Effects of octreotide on insulin-like growth factor I and metabolic indices in growth hormone-treated growth hormone-deficient patients
T Laursen, J O Jørgensen, H Orskov, et al.
Medicine
|
September 1, 1994
Acromegaly. Clinical and biochemical features in 500 patients
S Ezzat, M J Forster, P Berchtold, et al.
Neurosurgery
|
October 8, 1997
A prospective multicenter trial of octreotide in 24 patients with visual defects caused by nonfunctioning and gonadotropin-secreting pituitary adenomas. French Multicenter Octreotide Study Group
A Warnet, A G Harris, E Renard, et al.
Hormone Research
|
January 1, 1989
Experience of a six-month treatment with sandostatin at increasing doses in acromegaly
G Sassolas, P Fossati, P Chanson, et al.
Digestive Diseases and Sciences
|
April 1, 1991
Pilot study of sandostatin (octreotide) therapy of refractory HIV-associated diarrhea
M Fanning, M Monte, L R Sutherland, et al.
Kidney International
|
April 1, 1992
Octreotide administration in diabetic rats: effects on renal hypertrophy and urinary albumin excretion
A Flyvbjerg, S M Marshall, J Frystyk, et al.
Acta Endocrinologica
|
April 1, 1991
Shrinkage of a primary thyrotropin-secreting pituitary adenoma treated with the long-acting somatostatin analogue octreotide (SMS 201-995)
A Warnet, E Lajeunie, F Gelbert, et al.
The American Journal of Physiology
|
April 8, 1998
Mechanisms of cell injury in rat mesentery and cremaster muscle
A G Harris, J J Costa, F A Delano, et al.
Microcirculation (New York, N.Y. : 1994)
|
September 29, 1999
Mast cell degranulation and parenchymal cell injury in the rat mesentery
J J Costa, A G Harris, F A Delano, et al.
Page
of 15